For queries relating to News Releases, please contact:
Dr. Sarah L. White
[+1] 212 450 1543 - Business hours, EST (GMT -5 hours)
[+1] 917 379 0398 - After hours, EST (GMT -5 hours)
Email: swhite@licr.org
This regularly updated section reflects the diversity of interests and activities of the LICR community. It focuses on recent findings, newly published results, and other news-worthy LICR events.
August 6, 2009
Researchers at the San Diego Branch of the Ludwig Institute for Cancer Research and the Moores Cancer Center at the University of California, San Diego have pinpointed a large number of genes that can prevent a type of genetic rearrangement that may lead to cancer and other diseases. The study was published today in the advance online publication of Nature.
July 28, 2009
A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor. CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma. The study, published this week in the Early Edition of the Proceedings of the National Academy of Sciences, was led by the international Ludwig Institute for Cancer Research (LICR).